American Biogenetic Sciences, Inc.
40 Wall Street, 28th Floor
New York, NY 10005
Phone: 212-400-7198
On September 19, 2002, the Registrant filed a petition under the U.S. Bankruptcy Code in the U.S. Bankruptcy Court for the Eastern District of New York. On November 4, 2005, the Bankruptcy Court approved an order authorizing a change in control and provided that the Company, subsequent to the bankruptcy proceeding, is free and clear of all liens, claims and other obligations.
Management believes that as a result of the relative uncertainty in the United States equity markets over the past years, many privately-held companies have been closed off from the public market and traditional IPOs. During the past few years, many privately-held as well as public companies attempted to divest non-core assets and divisions and valuations of these assets and divisions have often decreased significantly. Therefore, Management believes that there are substantial business opportunities to effect attractive acquisitions. As a public entity with its shares of common stock registered under the Exchange Act and publicly trading, Management believes to be well positioned to identify target acquisitions and to effect a business combination in order to take advantage of these current trends.
Estimated Market Cap
$215,270 (12/31/10)
Outstanding Shares
1,088,740 (12/31/10)
Authorized Shares
900,000,000 (12/31/10)
Number of Share Holders of Record
640 (12/31/10)
Company's financials are current
This is a fully reporting OTC.BB Shell
SEC Filings: http://www.pinksheets.com/quote/filings.jsp?symbol=MABAA
Change of Control Date Forward (8/13/10):
